The association between red cell distribution width, erythropoietin levels, and coronary artery disease

Coronary Artery Disease

Volumn 29, Issue 1, 2018, Pages 74-80

  Li, Yuanmin ^a   Li, Min ^a,c   Teng, Yufang ^b   Zhang, Chen ^a   Liu, Qinghua ^a   Hou, Haifeng ^a,d  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b Taian Central Hospital   (China)

^c SHANDONG UNIVERSITY   (China)

^d EDITH COWAN UNIVERSITY   (Australia)

Author keywords

coronary artery disease; erythropoietin; red cell distribution width

Indexed keywords

ERYTHROPOIETIN; EPO PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DEMOGRAPHY; FEMALE; GENSINI SCORE; HUMAN; INTERVIEW; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE LINEAR REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RED BLOOD CELL DISTRIBUTION WIDTH; RISK ASSESSMENT; AGED; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; MEAN CORPUSCULAR VOLUME; RISK FACTOR; STATISTICAL MODEL;

AGED; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; ERYTHROCYTE INDICES; ERYTHROPOIETIN; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 85038847637     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000554     Document Type: Article

References (27)

1. Kaya MG, Yarlioglues M, Gunebakmaz O, Gunturk E, Inanc T, Dogan A, et al. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 2010; 209:278-282.
2. Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 2009; 169:588-594.
3. Fukuta H, Ohte N, Mukai S, Saeki T, Asada K, Wakami K, et al. Elevated plasma levels of B type natriuretic peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J 2009; 50:301-312.
4. Uyarel H, Ergelen M, Cicek G, Kaya MG, Ayhan E, Turkkan C, et al. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 2011; 22:138-144.
5. Tonelli M, Tonelli M, Sacks F, Arnold M, Moye L, Davis B, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008; 117:163-181.
6. Bullard AJ, Govewalla P, Yellon DM. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo. Basic Res Cardiol 2005; 100:397-403.
7. Szummer K, Lindahl B, Sylvén C, Jernberg T. Relationship of plasma erythropoietin to long-term outcome in acute coronary syndrome. Int J Cardiol 2010; 143:165-170.
8. Y?as JW, Horrow JC, Horne BD. Persistent increase in red cell size distribution width after acute diseases: a biomarker of hypoxemia? Clin Chim Acta 2015; 448:107-117.
9. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51:606.
10. Koma Y, Onishi A, Matsuoka H, Oda N, Yokota N, Matsumoto Y, et al. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS One 2013; 8:e80240.
11. Malandrino N, Wu WC, Taveira TH, Whitlatch HB, Smith RJ. Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes. Diabetologia 2012; 55:226-235.
12. Seyhan EC, Özgül MA, Tutar N, Ömür I, Uysal A, Altin S. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. COPD 2013; 10:416-424.
13. Van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, Januzzi JL Jr. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 2010; 12:129-136.
14. Adamsson Eryd S, Borné Y, Melander O, Persson M, Smith JG, Hedblad B, et al. Red blood cell distribution width is associated with incidence of atrial fibrillation. J Intern Med 2014; 275:84-92.
15. Zalawadiya SK, Veeranna V, Panaich SS, Afonso L. Red cell distribution width and risk of coronary heart disease events. Am J Cardiol 2010; 106:988-993.
16. Lippi G, Filippozzi L, Montagnana M, Salvagno GL, Franchini M, Guidi GC, et al. Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med 2009; 47:353-357.
17. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50:40-47.
18. Pascual-Figal DA, Bonaque JC, Redondo B, Caro C, Manzano-Fernandez S, Sánchez-Mas J, et al. Red blood cell distribution predicts long-term outcome regardless of anemia status in acute heart failure patients. Eur J Heart Fail 2009; 11:840-846.
19. Kario K, Matsuo T, Nakao K, Yamaguchi N. The correlation between red cell distribution width and serum erythropoietin titres. Clin Lab Haematol 1991; 13:222-223.
20. Lipsic E, van der Meer P, Henning RH, Suurmeijer AJ, Boddeus KM, van Veldhuisen DJ, et al. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J Cardiovasc Pharmacol 2004; 44:473-479.
21. Belonje AM, Voors AA, van der Meer P, van Gilst WH, Jaarsma T, van Veldhuisen DJ. Endogenous erythropoietin and outcome in heart failure. Circulation 2010; 121:245-251.
22. Erbayraktar S, Yilmaz O, Gökmen N, Brines M. Erythropoietin is a multifunctional tissue-protective cytokine. Curr Hematol Rep 2003; 2:465-470.
23. Ratajczak J, Majka M, Kijowski J, Baj M, Pan ZK, Marquez LA, et al. Biological significance of MAPK, AKT and JAK-STAT protein activation by various erythropoietic factors in normal human early erythroid cells. Br J Haematol 2001; 115:195-204.
24. Hou H, Sun T, Li C, Li Y, Guo Z, Wang W, Li D. An overall and doseresponse meta-analysis of red blood cell distribution width and CVD outcomes. Sci Rep 2017; 7:43420.
25. Tada H, Kagaya Y, Takeda M, Ohta J, Asaumi Y, Satoh K, et al. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion. Cardiovasc Res 2006; 71:466-477.
26. Emans ME, van der Putten K, van Rooijen KL, Kraaijenhagen RJ, Swinkels D, van Solinge WW, et al. Determinants of red cell distribution width (RDW) in cardiorenal patients: RDWis not related to erythropoietin resistance. J Card Fail 2011; 17:626-633.
27. Afsar B, Saglam M, Yuceturk C, Agca E. The relationship between red cell distribution width with erythropoietin resistance in iron replete hemodialysis patients. Eur J Intern Med 2013; 24:e25-e29.